Kortunay, S <br/><br/>
Dose-dependent inhibition of the CYP2D6 catalyzed oxidation of sparteine by mepyramine in healthy volunteers.  [electronic resource] 

 -  Pharmacology & toxicology  Dec 2001 
 - 331-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0901-9928 
<br/><br/><label>Standard No.: </label>10.1034/j.1600-0773.2001.d01-170.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Arrhythmia Agents--metabolism<br/>Catalysis<br/>Cytochrome P-450 CYP2D6 Inhibitors<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Histamine H1 Antagonists--pharmacology<br/>Humans<br/>Oxidation-Reduction<br/>Pyrilamine--pharmacology<br/>Sparteine--metabolism